Acarbose
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 80.0
Albiglutide
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 80.0
Canagliflozin
Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 80.0
Linagliptin
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 80.0
Semaglutide
Biologic · tier A · 8 trials (2 recruiting) · 14 publications · score 80.0
Glipizide
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 78.5
Exenatide
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 78.0
Glimepiride
Drug · tier A · 8 trials (0 recruiting) · 10 publications · score 78.0
Liraglutide
Biologic · tier A · 8 trials (0 recruiting) · 14 publications · score 78.0
Fenofibrate
Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 68.0
Irbesartan
Drug · tier A · 8 trials (1 recruiting) · 7 publications · score 68.0
Metoprolol
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 68.0
Ticagrelor
Drug · tier A · 8 trials (0 recruiting) · 7 publications · score 67.0
Metformin Hydrochloride
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 64.0
Berberine
Supplement · tier C · 8 trials (1 recruiting) · 13 publications · score 61.0
Omega-3 fatty acids
Supplement · tier C · 8 trials (1 recruiting) · 15 publications · score 57.5
Cinnamon
Supplement · tier C · 8 trials (1 recruiting) · 14 publications · score 56.5
Melatonin
Supplement · tier C · 7 trials (1 recruiting) · 13 publications · score 56.5
Magnesium
Supplement · tier C · 8 trials (0 recruiting) · 15 publications · score 56.0
Resveratrol
Supplement · tier C · 8 trials (0 recruiting) · 13 publications · score 54.5
Probiotics
Supplement · tier C · 8 trials (0 recruiting) · 16 publications · score 52.5
Omega-3-Acid Ethyl Esters
Drug · tier A · 8 trials (0 recruiting) · 2 publications · score 52.0
Alogliptin Benzoate
Drug · tier A · 7 trials (0 recruiting) · 1 publications · score 42.5
Time-restricted eating (Intermittent fasting)
Behavioural · tier C · 8 trials (2 recruiting) · 0 publications · score 26.5
Research map, not treatment advice. Built 2026-10-07.